MUNICH, Sept. 1 -- The latest round in the surgeons versus interventional cardiologists appears to have gone to the surgeons. So it would seem from today's roundtable discussion at the European Society of Cardiology meeting here.
In this exclusive ľֱ video report, American Heart Association president Timothy Gardner, M.D., a cardiovascular surgeon from the Heart and Vascular Institute at Christiana Care in Wilmington, Del., joined American College of Cardiology spokesperson Spencer King, III, M.D., of the St. Joseph's Hospital Heart and Vascular Institute in Atlanta, and ESC spokesperson Ekart Fleck, M.D., of the German Heart Institute in Berlin, in dissecting the results of the SYNTAX trial. ľֱ executive editor Peggy Peck moderated.